Michael Plevan is an experienced leader in the biotechnology and pharmaceutical sectors, currently serving as the Director of New Product Planning in Oncology at Eli Lilly and Company. With a robust background in analytics, forecasting, and market modeling, Michael has previously held key positions such as Senior Manager of Business Intelligence & Insights at Shoppers Drug Mart and Director of Commercial Operations at POINT Biopharma. Michael’s expertise in radioligand therapy and oncology has contributed significantly to major corporate successes and improved patient outcomes. A graduate of Wilfrid Laurier University with a BBA in International Business & Management, Michael has built a reputation for strategic insight and effective team leadership throughout their career.
This person is not in the org chart
This person is not in any teams
This person is not in any offices